InsidersTradesSigma
Follow the VITRAFY LIFE SCIENCES LIMITED share price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €274.5m. The latest transaction was filed on 8 July 2026 (Mixed). Among the most active insiders: Brenton (Brent) Owens. All data is free.
Analysts rate VITRAFY LIFE SCIENCES LIMITED Strong Buy (bullish), based on 2 analysts. Average price target: A$4.98.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
VITRAFY LIFE SCIENCES LIMITED 是一家在 ASX 上市的公司，专注于生命科学领域。该公司致力于开发创新解决方案，以增进健康和福祉。